News
-
-
PRESS RELEASE
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
Simcere Pharmaceutical partners with Stanford Medicine to develop new therapies for Idiopathic Pulmonary Fibrosis, aiming to address unmet clinical needs. Collaboration will advance novel molecule research led by renowned experts -
-
-
-
-
-
-
PRESS RELEASE
Information relative au nombre total de droits de vote et d'actions composant le capital au 11 juin 2026
Diagnostic Medical Systems publie le nombre total de droits de vote et d'actions, DMS Group, acteur clé de la radiologie digitale, réalise un CA de 50 M€ en 2025, coté sur Euronext Growth Paris -